ArticleDrug and alcohol review2026
Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia?
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionWe are at a critical juncture for drug policy reform. Toxic drug supply is driving unprecedented deaths in North America, with countries calling for decriminalisation. Policy reform in Australia has occurred in some states (e.g., decriminalisation in the Australian Capital Territory), stalling in others (e.g., the second supervised injecting facility [SIF] in Victoria). The objectives of this paper are to present trends in attitudes to drug policy in Australia, 2001-2022/23 and media reporting of related policies, to explore how public opinion and media attention have changed over time.
methodsAnalysis of (i) National Drug Strategy Household Survey data on attitudes to drugs/drug policies; and (ii) Factiva for media reporting.
resultsIn 2022/23, Australians supported needle and syringe programs (67.8%), SIFs (58.3%), take home naloxone (60.9%) and drug checking services (64.4%). They opposed legalisation of methamphetamine (86.6%), heroin (85.6%), cocaine (78.2%) and ecstasy (75.8%), while a larger proportion supported cannabis legalisation (44.6%). Australians supported a health response to possession of drugs (57.3% for methamphetamine, 80.9% for cannabis) rather than a criminal response. Methamphetamine was increasingly reported as the drug of most concern (2.9%-42.5%), decreasing for heroin (44.9%-11.4%), 2001-2022/23. Methamphetamine media articles increased (272-2426); heroin decreased (2136-973), 2000-2023. Mentions increased for SIFs (spiking at 175, 2019) and decriminalisation/legalisation (spiking at 242, 2019). DISCUSSION AND
conclusionsSupport for harm reduction remains high and low for legalisation. Media focused on methamphetamine, SIFs and decriminalisation/legalisation. Despite opposition towards legalisation, most Australians favoured a health response to drug use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.